Paul Yuratich, MD
Pediatrics · New Orleans, LANPI 1871687772
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 465 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations. Among pediatrics clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 465 payments — averaging $18.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Pfizer$1K
- GSK$1K
- Lilly USA, LLC$1K
- AbbVie$766
- Novo Nordisk$330
- plus $3K from 30 others
What the payments were for
- Food & beverage$8,619100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 54 | $1,327 |
| Pfizer | 81 | $1,209 |
| GSK | 69 | $1,205 |
| Lilly USA, LLC | 62 | $1,107 |
| AbbVie(2 entities) | 40 | $766 |
| Novo Nordisk | 16 | $330 |
| Boehringer Ingelheim | 17 | $302 |
| Merck | 17 | $276 |
| Amgen | 13 | $273 |
| Otsuka America Pharmaceutical, Inc. | 13 | $225 |
| Novartis | 9 | $165 |
| Bayer | 8 | $163 |
| Abbott | 2 | $154 |
| Lundbeck LLC | 6 | $117 |
| Idorsia Pharmaceuticals US Inc | 7 | $111 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $95 |
| Johnson & Johnson | 7 | $94 |
| Kowa Pharmaceuticals America, Inc. | 5 | $82 |
| Exact Sciences | 3 | $73 |
| Alnylam Pharmaceuticals Inc. | 2 | $62 |
| Sanofi-aventis U.S. LLC | 3 | $56 |
| Dexcom, Inc. | 2 | $49 |
| E.r. Squibb & Sons, L.L.C. | 3 | $49 |
| Astellas Pharma US Inc | 2 | $45 |
| Ironwood Pharmaceuticals, Inc | 3 | $43 |
| Corcept Therapeutics | 2 | $40 |
| Amarin Pharma, Inc. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $32 |
| Gilead | 2 | $25 |
| Sanofi Pasteur Inc. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Boston Scientific | 1 | $18 |
| Shield Therapeutics Inc | 1 | $15 |
| Vifor Pharma, Inc. | 1 | $12 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$228
- FreeStyle Libre Pro$133
- Tresiba$117
- AIRSUPRA$103
How this compares
$8,633 in reported general payments places this provider in the 95th percentile of 913 pediatrics providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 154 | $108,673 |
| JanuviaSitagliptin Phosphate | 73 | $85,832 |
| EliquisApixaban | 94 | $84,520 |
| JardianceEmpagliflozin | 58 | $78,402 |
| TrulicityDulaglutide | 53 | $62,225 |
| OzempicSemaglutide | 48 | $59,711 |
| XareltoRivaroxaban | 42 | $36,852 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 36 | $34,443 |
| EntrestoSacubitril/Valsartan | 25 | $22,314 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 39 | $20,775 |
| LinzessLinaclotide | 21 | $20,119 |
| Breo ElliptaFluticasone/Vilanterol | 32 | $14,483 |
| Nurtec OdtRimegepant Sulfate | 11 | $12,605 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 12 | $8,392 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 294 | $8,098 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Brilinta, Symbicort | $1,327 | $120,028184 claims |
| PfizerEliquis, Nurtec Odt | $1,209 | $97,125105 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat, Combivent Respimat | $302 | $92,21381 claims |
| MerckJanuvia | $276 | $85,83273 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta | $1,205 | $77,628124 claims |
| Lilly USA, LLCTrulicity | $1,107 | $62,22553 claims |
| Novo NordiskOzempic | $330 | $59,71148 claims |
| Johnson & JohnsonXarelto | $94 | $36,85242 claims |
| NovartisEntresto | $165 | $22,31425 claims |
| AbbVieLinzess | $766 | $20,11921 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 913 pediatrics providers in Louisiana.
Other pediatrics in New Orleans
- Melissa NunnNew Orleans$5K
- Veronica LewisNew Orleans$4K
- Nicole TaylorNew Orleans$4K
- James TreadwayNew Orleans$3K
- Corey HebertGretna$1.3M
- Katie QueenBogalusa$61K
- Elizabeth WhiteCovington$19K
- Neslihan GungorShreveport$16K
- Amy VitteLafayette$10K
- Alicia NicklasLafayette$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.